PTX 2.56% 4.0¢ prescient therapeutics limited

Ann: PTX successful immunogenicity testing of OmniCAR, page-47

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 807 Posts.
    lightbulb Created with Sketch. 292
    I take away two messages from the announcement:

    1. Omni-CAR is ready as it is safe for initiating clinical trials and ready for licensing with the in silico tests and coupled with the recent success in manufacturing. I see that PTX has now the full omni-CAR platform and hence there should be a big re-rate to its value and hence market cap. There will always be down rampers but remember that a stock always grows on skeptism and so let it be..

    2. I'm delighted to see PTX starts to apply latest computer technology in Omni-CAR, which demonstrated the advanced thinking in the management team. Use of computer simulation only means one thing -- acceleration! Use of In Silico means that PTX is likely to get into DNA/RNA sequencing technology, and perhaps CRISPR in the future!

    That's why I think PTX can emulate IMU. Great stock to hold for a long time. GLTA!

    Last edited by free2nap: 05/07/21
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.